Skip to main content
Log in

Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The use of cardiac and hepatic T2* MRI measurements to predict the amount of iron accumulation in these organs has been studied extensively and was suggested to be used reliably. However, it may not be practical to screen other organs with MRI related to economical issues and also the prolonged imaging durations. Herein, we aimed to test the use of fasting glucose, fasting, and postprandial insulin, homeostasis model assessment-insulin resistance (HOMA-IR) (calculated as insulin (μIU/ml) × glucose (mg/dl)/22.5), and homeostasis model assessment B score (HOMA-B) (calculated as insulin (μIU/ml) × 20/glucose (mg/dl) − 3.5) to estimate the tissue iron measured with MRI. A total of 37 patients with β-thalassemia major (BTM), age 20.8 ± 6.3 years (7.1–36.8), were enrolled. MRI measurements were done concomitantly to the biochemical tests for glucose metabolism. A positive correlation between HOMA-IR and hepatic iron loading and a negative correlation between pancreatic T2* and fasting blood glucose were found. A positive correlation was found between fasting insulin levels and pancreatic R2* measures. Additionally, a correlation was detected between cardiac and pancreatic iron accumulations. In centers where T2*/R2* MRI facilities are unavailable, fasting insulin, fasting glucose, and HOMA-IR measurements may be used to predict iron overload and may urge the physician for MRI assessment in case of a deterioration in these biochemical tests. Since hepatic iron loading correlated with insulin resistance development, the insulin resistance among patients with BTM may partially be explained with decreased hepatic insulin clearance from heavily iron-loaded liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A (2008) Guidelines for the clinical management of thalassaemia, 2nd edn. Thalassaemia International Federation, Nicosia

    Google Scholar 

  2. Cunningham MJ, Sankaran VG, Nathan DG, Orkin SH (2009) The Thalassemias. In: Nathan DG, Orkin SH (eds) Nathan and Oski’s hematology of infancy and childhood, 7th edn. WB Saunders, Philadelphia, pp 1015–1106

    Google Scholar 

  3. Li MJ, Peng SS, Lu MY, Chang HH, Yang YL, Jou ST, Lin DT, Lin KH (2014) Diabetes mellitus in patients with thalassemia major. Pediatr Blood Cancer 61:20–24. doi:10.1002/pbc.24754

    Article  PubMed  Google Scholar 

  4. Cario H, Holl RW, Debatin KM, Kohne E (2003) Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 162:139–146

    CAS  PubMed  Google Scholar 

  5. De Assis RA, Ribeiro AA, Kay FU, Rosemberg LA, Nomura CH, Loggetto SR, Araujo AS, Fabron Junior A, de Almeida Veríssimo MP, Baldanzi GR, Espósito BP, Baroni RH, Wood JC, Hamerschlak N (2012) Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients. Eur J Radiol 81:1465–1470. doi:10.1016/j.ejrad.2011.03.077

    Article  PubMed  Google Scholar 

  6. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, Piga A, Pagano G (1995) Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia. Metabolism 44:281–286

    Article  CAS  PubMed  Google Scholar 

  7. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J (2007) Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol 21:4699–4706

    Google Scholar 

  8. Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G (2004) Glucose metabolism disorders improvement in patients with thalassaemia major after 24–36 months of intensive chelation therapy. Pediatr Endocrinol Rev 2:279–281

    PubMed  Google Scholar 

  9. Au WY, Lam WW, Chu W, Tam S, Wong WK, Liang R, Ha SY (2008) A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica 93:116–119. doi:10.3324/haematol.11768

    Article  PubMed  Google Scholar 

  10. Ooi GC, Khong PL, Chan GC, Chan KN, Chan KL, Lam W, Ng I, Ha SY (2004) Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. Br J Haematol 124:385–390

    Article  CAS  PubMed  Google Scholar 

  11. Noetzli LJ, Papudesi J, Coates TD, Wood JC (2009) Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 114:4021–4026. doi:10.1182/blood-2009-06-225615

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Barlow SE (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120:164–192

    Article  Google Scholar 

  13. CDC, “National health and nutrition examination survey: anthropometry procedures manual,” August 2014, http://www.cdc.gov/nchs/data/nhanes/nhanes1112/AnthropometryProceduresManual.pdf

  14. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343:327–331

    Article  CAS  PubMed  Google Scholar 

  15. Lam WW, Au WY, Chu WC, Tam S, Ha SY, Pennell DJ (2008) One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging 28:29–33. doi:10.1002/jmri.21433

    Article  PubMed  Google Scholar 

  16. Noetzli LJ, Panigrahy A, Mittelman SD, Hyderi A, Dongelyan A, Coates TD, Wood JC (2012) Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol 87:167–171. doi:10.1002/ajh.22247

    Article  CAS  PubMed  Google Scholar 

  17. Borgna-Pignatti C, Meloni A, Guerrini G, Gulino L, Filosa A, Ruffo GB, Casini T, Chiodi E, Lombardi M, Pepe A (2014) Myocardial iron overload in thalassaemia major. How early to check? Br J Haematol 164:579–585. doi:10.1111/bjh.12643

    Article  CAS  PubMed  Google Scholar 

  18. Yang G, Liu R, Peng P, Long L, Zhang X, Yang W, Tan S, Pan H, Long X, He T, Anderson L, Lai Y (2014) How early can myocardial iron overload occur in beta thalassemia major? PLoS One 9:e85379. doi:10.1371/journal.pone.0085379

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

All of the authors namely Munevver Bas, Fatma Gumruk, Nazlı Gonc, Mualla Cetin, Murat Tuncer, Tuncay Hazırolan, Gokce Yildirim, Erdem Karabulut, and Sule Unal contributed equally in the research design, acquisition, analysis, or interpretation of data. The study has not been financially supported.

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sule Unal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bas, M., Gumruk, F., Gonc, N. et al. Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major. Ann Hematol 94, 1099–1104 (2015). https://doi.org/10.1007/s00277-015-2342-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2342-y

Keywords

Navigation